4.5 Review

Lipid metabolism reprogramming in renal cell carcinoma

Related references

Note: Only part of the references are listed.
Article Medicine, General & Internal

Nivolumab plus Cabozantinib versus Sunitinib for Advanced Renal-Cell Carcinoma

T. K. Choueiri et al.

Summary: The study demonstrates that nivolumab plus cabozantinib has significant advantages over sunitinib in the treatment of previously untreated advanced renal-cell carcinoma, including progression-free survival, overall survival, and likelihood of response.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Article Medicine, General & Internal

Lenvatinib plus Pembrolizumab or Everolimus for Advanced Renal Cell Carcinoma

Robert Motzer et al.

Summary: The study demonstrated that the combination of lenvatinib with pembrolizumab led to significantly longer progression-free survival and overall survival than sunitinib, while the combination of lenvatinib with everolimus showed longer progression-free survival but not overall survival compared to sunitinib. Adverse events were more frequent in patients receiving lenvatinib-based treatments.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Article Oncology

A HIF1α-GPD1 feedforward loop inhibits the progression of renal clear cell carcinoma via mitochondrial function and lipid metabolism

Ren Liu et al.

Summary: In clear cell renal cell carcinoma (ccRCC), HIF1 alpha inhibits mitochondrial function and lipid metabolism by directly regulating GPD1, thus impacting tumor activity. This study provides new insights into the treatment of ccRCC and reveals a novel mechanism for the molecular basis of HIF1 alpha inhibition of tumor activity.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2021)

Article Medicine, General & Internal

First-in-human study of the safety, pharmacokinetics, and pharmacodynamics of first-in-class fatty acid synthase inhibitor TVB-2640 alone and with a taxane in advanced tumors

Gerald Falchook et al.

Summary: The study aimed to determine the MTD and RP2D of oral FASN inhibitor TVB-2640 and evaluate its safety and efficacy in monotherapy and in combination with paclitaxel. Results showed potent FASN inhibition with manageable toxicity primarily affecting skin and eyes, supporting further investigation particularly in KRASMUT lung, ovarian, and breast cancer patients.

ECLINICALMEDICINE (2021)

Article Cell Biology

Study of FABP's interactome and detecting new molecular targets in clear cell renal cell carcinoma

Guangzhen Wu et al.

JOURNAL OF CELLULAR PHYSIOLOGY (2020)

Review Oncology

Reprogramming of fatty acid metabolism in cancer

Nikos Koundouros et al.

BRITISH JOURNAL OF CANCER (2020)

Article Oncology

Cancer statistics, 2020

Rebecca L. Siegel et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2020)

Review Cell Biology

Greasing the Wheels of the Cancer Machine: The Role of Lipid Metabolism in Cancer

Marteinn Thor Snaebjornsson et al.

CELL METABOLISM (2020)

Article Medicine, General & Internal

Statin use and the risk of renal cell carcinoma: national cohort study

Yu-Ching Chou et al.

JOURNAL OF INVESTIGATIVE MEDICINE (2020)

Review Biochemistry & Molecular Biology

Cholesterol and beyond - The role of the mevalonate pathway in cancer biology

Andy Goebel et al.

BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2020)

Letter Biotechnology & Applied Microbiology

Visualizing and interpreting cancer genomics data via the Xena platform

Mary J. Goldman et al.

NATURE BIOTECHNOLOGY (2020)

Review Oncology

Statins as Anticancer Agents in the Era of Precision Medicine

Joseph Longo et al.

CLINICAL CANCER RESEARCH (2020)

Review Medicine, General & Internal

Targeted therapy for metastatic renal cell carcinoma

Fabian Hofmann et al.

COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2020)

Article Hematology

Lysosomal Acid Lipase in Lipid Metabolism and Beyond

Fang Li et al.

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2019)

Article Medicine, General & Internal

Pembrolizumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma

Brian I. Rini et al.

NEW ENGLAND JOURNAL OF MEDICINE (2019)

Article Biochemistry & Molecular Biology

Uptake of HDL-cholesterol contributes to lipid accumulation in clear cell renal cell carcinoma

JungYeon Kim et al.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2019)

Review Cell Biology

Dynamics and functions of lipid droplets

James A. Olzmann et al.

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2019)

Review Physiology

SR-B1: A Unique Multifunctional Receptor for Cholesterol Influx and Efflux

Wen-Jun Shen et al.

ANNUAL REVIEW OF PHYSIOLOGY, VOL 80 (2018)

Article Oncology

Targeting the Mevalonate Pathway Suppresses VHL-Deficient CC-RCC through an HIF-Dependent Mechanism

Jordan M. Thompson et al.

MOLECULAR CANCER THERAPEUTICS (2018)

Review Endocrinology & Metabolism

Liver X receptors in lipid signalling and membrane homeostasis

Bo Wang et al.

NATURE REVIEWS ENDOCRINOLOGY (2018)

Review Oncology

Targeting Mevalonate Pathway in Cancer Treatment: Repurposing of Statins

Federica Iannelli et al.

RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY (2018)

Review Urology & Nephrology

Metabolomics and Metabolic Reprogramming in Kidney Cancer

Robert H. Weiss

SEMINARS IN NEPHROLOGY (2018)

Review Cell Biology

Hints on ATGL implications in cancer: beyond bioenergetic clues

Rolando Vegliante et al.

CELL DEATH & DISEASE (2018)

Article Multidisciplinary Sciences

FABP4 as a key determinant of metastatic potential of ovarian cancer

Kshipra M. Gharpure et al.

NATURE COMMUNICATIONS (2018)

Review Biotechnology & Applied Microbiology

Targeting CD36 as Biomarker for Metastasis Prognostic: How Far from Translation into Clinical Practice?

Ana-Maria Enciu et al.

BIOMED RESEARCH INTERNATIONAL (2018)

Review Endocrinology & Metabolism

SREBP-regulated lipid metabolism: convergent physiology - divergent pathophysiology

Hitoshi Shimano et al.

NATURE REVIEWS ENDOCRINOLOGY (2017)

Article Multidisciplinary Sciences

HIF drives lipid deposition and cancer in ccRCC via repression of fatty acid metabolism

Weinan Du et al.

NATURE COMMUNICATIONS (2017)

Article Medicine, General & Internal

Renal cell carcinoma

James J. Hsieh et al.

NATURE REVIEWS DISEASE PRIMERS (2017)

Article Pharmacology & Pharmacy

Dietary cholesterol promotes AOM-induced colorectal cancer through activating the NLRP3 inflammasome

Qianming Du et al.

BIOCHEMICAL PHARMACOLOGY (2016)

Article Oncology

Statins and survival outcomes in patients with metastatic renal cell carcinoma

Rana R. Mckay et al.

EUROPEAN JOURNAL OF CANCER (2016)

Review Urology & Nephrology

The Nephrologist's Tumor: Basic Biology and Management of Renal Cell Carcinoma

Susie L. Hu et al.

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2016)

Review Cell Biology

Regulating Rho GTPases and their regulators

Richard G. Hodge et al.

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2016)

Article Multidisciplinary Sciences

Lipidomic Signatures and Associated Transcriptomic Profiles of Clear Cell Renal Cell Carcinoma

Kosuke Saito et al.

SCIENTIFIC REPORTS (2016)

Review Oncology

The multifaceted roles of fatty acid synthesis in cancer

Florian Roehrig et al.

NATURE REVIEWS CANCER (2016)

Review Oncology

The interplay between cell signalling and the mevalonate pathway in cancer

Peter J. Mullen et al.

NATURE REVIEWS CANCER (2016)

Review Biochemistry & Molecular Biology

Lipid Droplets: A Key Cellular Organelle Associated with Cancer Cell Survival under Normoxia and Hypoxia

Shiro Koizume et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)

Article Oncology

Preoperative serum docosahexaenoic acid level predicts prognosis of renal cell carcinoma

Shinsuke Tasaki et al.

MOLECULAR AND CLINICAL ONCOLOGY (2016)

Article Gastroenterology & Hepatology

Prostaglandin E2 Promotes Colorectal Cancer Stem Cell Expansion and Metastasis in Mice

Dingzhi Wang et al.

GASTROENTEROLOGY (2015)

Review Oncology

Lipogenesis in cancer progression (Review)

Catherine Mounier et al.

INTERNATIONAL JOURNAL OF ONCOLOGY (2014)

Review Oncology

Marine polyunsaturated fatty acids and cancer therapy

V. C. Vaughan et al.

BRITISH JOURNAL OF CANCER (2013)

Article Oncology

Stearoyl-CoA Desaturase 1 Is a Novel Molecular Therapeutic Target for Clear Cell Renal Cell Carcinoma

Christina A. von Roemeling et al.

CLINICAL CANCER RESEARCH (2013)

Article Multidisciplinary Sciences

Comprehensivemolecular characterization of clear cell renal cell carcinoma

Chad J. Creighton et al.

NATURE (2013)

Editorial Material Pharmacology & Pharmacy

Cholesterol metabolism and cancer: the good, the bad and the ugly

Sandrine Silvente-Poirot et al.

CURRENT OPINION IN PHARMACOLOGY (2012)

Article Pharmacology & Pharmacy

Cholesterol and the development of clear-cell renal carcinoma

Harry A. Drabkin et al.

CURRENT OPINION IN PHARMACOLOGY (2012)

Review Biochemistry & Molecular Biology

Lipid metabolism in cancer

Claudio R. Santos et al.

FEBS JOURNAL (2012)

Article Biochemistry & Molecular Biology

Overexpression of FABP3 promotes apoptosis through inducing mitochondrial impairment in embryonic cancer cells

Gui Xian Song et al.

JOURNAL OF CELLULAR BIOCHEMISTRY (2012)

Article Biochemical Research Methods

Analysis of Renal Cell Carcinoma as a First Step for Developing Mass Spectrometry-Based Diagnostics

Kentaro Yoshimura et al.

JOURNAL OF THE AMERICAN SOCIETY FOR MASS SPECTROMETRY (2012)

Article Multidisciplinary Sciences

SCD1 Inhibition Causes Cancer Cell Death by Depleting Mono-Unsaturated Fatty Acids

Paul Mason et al.

PLOS ONE (2012)

Article Pharmacology & Pharmacy

Inhibition of AMPK-dependent autophagy enhances in vitro antiglioma effect of simvastatin

Maja Misirkic et al.

PHARMACOLOGICAL RESEARCH (2012)

Article Nutrition & Dietetics

Changes in consumption of omega-3 and omega-6 fatty acids in the United States during the 20th century

Tanya L. Blasbalg et al.

AMERICAN JOURNAL OF CLINICAL NUTRITION (2011)

Article Oncology

New Insights into the Biology of Renal Cell Carcinoma

Lianjie Li et al.

HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2011)

Article Oncology

Total Cholesterol and Cancer Risk in a Large Prospective Study in Korea

Cari M. Kitahara et al.

JOURNAL OF CLINICAL ONCOLOGY (2011)

Review Endocrinology & Metabolism

Biochemical and physiological function of stearoyl-CoA desaturase

Chad M. Paton et al.

AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2009)

Article Public, Environmental & Occupational Health

Body size and renal cell cancer incidence in a large US cohort study

Kenneth F. Adams et al.

AMERICAN JOURNAL OF EPIDEMIOLOGY (2008)

Article Oncology

Improved identification of von Hippel-Lindau gene alterations in clear cell renal tumors

Michael L. Nickerson et al.

CLINICAL CANCER RESEARCH (2008)

Review Oncology

Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis

Javier A. Menendez et al.

NATURE REVIEWS CANCER (2007)

Review Medical Laboratory Technology

Mevalonate pathway: A review of clinical and therapeutical implications

Irina Buhaescu et al.

CLINICAL BIOCHEMISTRY (2007)

Article Biochemistry & Molecular Biology

Sterol-regulated degradation of Insig-1 mediated by the membrane-bound ubiquitin ligase gp78

Joon No Lee et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2006)

Article Oncology

ATP citrate lyase inhibition can suppress tumor cell growth

G Hatzivassiliou et al.

CANCER CELL (2005)

Article Biochemistry & Molecular Biology

Formation and anti proliferative effect of prostaglandin E3 from eicosapentaenoic acid in human lung cancer cells

PY Yang et al.

JOURNAL OF LIPID RESEARCH (2004)

Review Medicine, General & Internal

von Hippel-Lindau disease

RR Lonser et al.

LANCET (2003)

Review Biochemistry & Molecular Biology

Recent advances in the study of prenylated proteins

M Sinensky

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2000)